Swedish Drug Biz Camurus Raises $104M With Share Issue
Camurus AB said on Thursday it has raised 1.09 billion Swedish kronor ($104 million) via a share issue, which the Swedish pharmaceutical company will use in the development and launch of its...To view the full article, register now.
Already a subscriber? Click here to view full article